Efter intravenøs administration af Cyanokit forekommer der en signifikant binding til plasmaproteiner og fysiologiske stoffer med lav molekylær vægt.
Following intravenous administration of Cyanokit, significant binding to plasma proteins and low molecular weight physiological compounds occurs, to form various cobalamin-(III) complexes by replacing the hydroxo ligand.